Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,077,444
-$1,253,180 QoQ
Shares Held
38,779
-19.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#239
of 1,603 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. NVS ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,077,444 | 38,779 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $7,330,624 | 47,991 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,122,944 | 44,411 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,048,680 | 39,369 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,616,395 | 71,204 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $5,292,066 | 47,471 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $12,543,939 | 128,907 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $13,445,607 | 116,898 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $18,949,879 | 178,000 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $14,140,764 | 146,188 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,245,250 | 141,084 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $14,246,546 | 139,864 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $13,648,985 | 135,259 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $12,276,940 | 133,445 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $13,174,449 | 145,221 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $10,960,565 | 144,199 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $11,598,275 | 137,209 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $11,028,682 | 125,683 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $12,910,134 | 147,595 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||